Final answer:
True, a drug can be classified as adulterated or misbranded if it does not meet its stated strength, quality, or purity, with the FDA and FTC ensuring safety and truthfulness in pharmaceuticals and advertising.
Step-by-step explanation:
It is indeed true that if a drug has inaccurate strength, quality, or purity, it can be both adulterated and misbranded. Adulteration refers to a drug not meeting its purported standards or specifications, potentially due to substandard ingredients or contamination.
Misbranding, on the other hand, involves incorrect or misleading information on the labeling, which can range from the listed strength of the drug to the benefits it provides. It's essential that consumers can trust the medication they use, and thus, regulatory agencies like the Food and Drug Administration (FDA) enforce strict compliance to ensure drugs on the market are safe and effective. The Federal Trade Commission (FTC) also regulates advertising to prevent the dissemination of false claims about a product's performance. This commitment to monitoring pharmaceuticals underscores the 'Caveat emptor' philosophy, which emphasizes the need for consumer awareness and vigilance.